Investors
Backing measurement infrastructure for the Gulf's biotech build-out
Quantabia combines a differentiated physical measurement with software economics in a market investing heavily in life science.
Highlights
Investment highlights
Platform economics
An expanding menu of cloud models increases the value of every installed instrument without new consumable development.
Recurring revenue
Instrument placement, consumable vials and cloud analysis subscriptions create compounding utilization rather than one-off sales.
Data moat
Archived spectra form a standardized, growing biological dataset that improves models and raises customer switching costs.
De-risked core
Licensed Probius technology is already validated across proteins, metabolites, drugs and microorganisms.
Market
Why Saudi Arabia and the GCC
GCC life-science investment
National strategies funding genomics, biomanufacturing and precision health.
Local capacity gap
Analytical work is routinely shipped abroad, adding weeks and cost per study.
Bioproduction growth
New regional manufacturing capacity needs release and in-process quality control.
Clinical research
Hospital networks are scaling translational programs that need high-frequency measurement.
Partners
Investors & Partners
Contact
Investor inquiries
Request the investor briefing pack or arrange a call with the founding team.